Literature DB >> 27842765

Drug Metabolism in the Liver.

Omar Abdulhameed Almazroo1, Mohammad Kowser Miah1, Raman Venkataramanan2.   

Abstract

Metabolism is a biotransformation process, where endogenous and exogenous compounds are converted to more polar products to facilitate their elimination from the body. The process of metabolism is divided into 3 phases. Phase I metabolism involves functionalization reactions. Phase II drug metabolism is a conjugation reaction. Phase III refers to transporter-mediated elimination of drug and/or metabolites from body normally via liver, gut, kidney, or lung. This review presents basic information on drug-metabolizing enzymes and potential factors that might affect the metabolic capacities of the enzyme or alter drug response or drug-mediated toxicities.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Conjugation; Cytochrome P450; Drug metabolism; Drug transporters; Liver metabolism; Phase I, II, and III metabolism enzyme

Mesh:

Substances:

Year:  2016        PMID: 27842765     DOI: 10.1016/j.cld.2016.08.001

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  81 in total

Review 1.  Predicting and Understanding the Human Microbiome's Impact on Pharmacology.

Authors:  Reese Hitchings; Libusha Kelly
Journal:  Trends Pharmacol Sci       Date:  2019-06-03       Impact factor: 14.819

2.  Translational and transcriptional responses in human primary hepatocytes under hypoxia.

Authors:  Gaya K Hettiarachchi; Upendra K Katneni; Ryan C Hunt; Jacob M Kames; John C Athey; Haim Bar; Zuben E Sauna; Joseph R McGill; Juan C Ibla; Chava Kimchi-Sarfaty
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-28       Impact factor: 4.052

3.  Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.

Authors:  Gianfranco Arroyo; Javier A Bustos; Andres G Lescano; Isidro Gonzales; Herbert Saavedra; Silvia Rodriguez; E Javier Pretell; Pierina S Bonato; Vera L Lanchote; Osvaldo M Takayanagui; John Horton; Armando E Gonzalez; Robert H Gilman; Hector H Garcia
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

4.  Dose-independent genotoxic response in A549 cell line exposed to fungicide Iprodione.

Authors:  Nancy B Andrioli; Gabriela Chaufan
Journal:  Arch Toxicol       Date:  2020-11-27       Impact factor: 5.153

5.  Interactions between Environmental Exposures and the Microbiome: Implications for Fetal Programming.

Authors:  Sohini Banerjee; Melissa A Suter; Kjersti M Aagaard
Journal:  Curr Opin Endocr Metab Res       Date:  2020-10-03

Review 6.  Gut-on-a-chip: Current progress and future opportunities.

Authors:  Nureddin Ashammakhi; Rohollah Nasiri; Natan Roberto de Barros; Peyton Tebon; Jai Thakor; Marcus Goudie; Amir Shamloo; Martin G Martin; Ali Khademhosseini
Journal:  Biomaterials       Date:  2020-06-14       Impact factor: 12.479

Review 7.  A Decade of Organs-on-a-Chip Emulating Human Physiology at the Microscale: A Critical Status Report on Progress in Toxicology and Pharmacology.

Authors:  Mario Rothbauer; Barbara E M Bachmann; Christoph Eilenberger; Sebastian R A Kratz; Sarah Spitz; Gregor Höll; Peter Ertl
Journal:  Micromachines (Basel)       Date:  2021-04-21       Impact factor: 2.891

8.  Generation of multi-cellular human liver organoids from pluripotent stem cells.

Authors:  Wendy L Thompson; Takanori Takebe
Journal:  Methods Cell Biol       Date:  2020-05-22       Impact factor: 1.441

9.  Engineered Liver Tissue Culture in an In Vitro Tubular Perfusion System.

Authors:  Guang Yang; Bhushan Mahadik; Trevor Mollot; Julia Pinsky; Athenia Jones; Alexis Robinson; Daniel Najafali; Daniel Rivkin; Jenny Katsnelson; Charlotte Piard; John P Fisher
Journal:  Tissue Eng Part A       Date:  2020-11-24       Impact factor: 3.845

10.  Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics.

Authors:  Yingchao Li; Yongjun Wang; Ran Zhang; Cuiru Liu; Yue Wei; Jin Sun; Zhonggui He; Youjun Xu; Tianhong Zhang
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.